Clinical Combination Drugs of Levodopa Against Parkinson's Paralysis

Authors

  • ZHOU Chenghe

Abstract

Levodopa (L-dopa) is currently the first choice drug for treating Parkinson's paralysis. Due to the large dose, long administration time and many side effects, it is often used in combination with other anti-Parkinson's drugs in clinical practice. This article describes L-dopa with dopa decarboxylase inhibitors (benserazide, carbidopa), dopamine receptor agonists (bromocriptine, ergonitrile), anticholinergics, antidepressants, amantadine, propranolol Clinical combination of other drugs.

Published

2022-04-04

Issue

Section

Articles